Drug
Kite 439
Kite 439: highest development phase Phase 1, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| KITE-439 NCT03912831 | Phase 1 | Human Papillomavirus (HPV) 16+ Relapsed/Refractory Cancer |
Latest
No recent events.
Follow Kite 439 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.